Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDARUBICIN vs IDURSULFASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDARUBICIN vs IDURSULFASE: Safety Overview

Metric IDARUBICIN IDURSULFASE
Total FAERS Reports 5,038 3,188
Deaths Reported 1,260 526
Death Rate 25.0% 16.5%
Hospitalizations 1,856 1,734
Average Patient Age 44.8 yrs 13.2 yrs
% Female Patients 46.2% 1.1%
FDA Approval Date Apr 25, 1995 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc Takeda Pharmaceuticals America, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Prescription